Voyager Technologies (VOYG) TD Cowen 47th Annual Aerospace & Defense Conference summary
Event summary combining transcript, slides, and related documents.
TD Cowen 47th Annual Aerospace & Defense Conference summary
12 Feb, 2026Business overview and strategy
Focuses on addressing critical pain points in aerospace, defense, and space by innovating where incumbents are slow to adapt.
Operates as a technology-driven, low-capital-intensity platform with high R&D investment (20% of revenue).
Pursues organic growth (25% organic CAGR guided through 2030) and augments capabilities through targeted M&A, not just revenue acquisition.
Maintains a strong balance sheet with over $400 million in cash and $200 million in undrawn credit facilities.
Attracts high-caliber management and board talent from both industry and government.
Starlab commercial space station initiative
Starlab is a joint venture with major international partners, aiming to replace the ISS by 2030 with a single-module, commercial off-the-shelf design.
Launch planned for 2029 on SpaceX Starship, enabling full capacity and rapid monetization upon deployment.
Unit economics: $4B annual revenue, $1.5B annual free cash flow, $3B build cost for the first station, with improved economics for future stations.
NASA is expected to reserve about 25% of capacity; strong demand from commercial and international customers, with capacity nearly sold out.
Starlab partners (Airbus, Mitsubishi, MDA, Palantir) bring both technology and international customer access; exclusivity agreements in place.
Competitive landscape and NASA programs
Competes in NASA's Commercial LEO Development (CLD) program; initial competitors included Blue Origin, Northrop Grumman (now a partner), and Axiom Space.
Next CLD phase will likely down-select to two providers, with $2.1B in NASA funding expected between 2026–2030.
NASA will transition to buying commercial services post-certification, with Starlab already selling capacity to governments and commercial entities.
Latest events from Voyager Technologies
- Record backlog and raised guidance signal strong growth despite Q1 net loss.VOYG
Q1 20265 May 2026 - Key votes include director elections and redomestication to Texas, with board support for all proposals.VOYG
Proxy filing21 Apr 2026 - Key votes include director elections, auditor ratification, and redomestication to Texas.VOYG
Proxy filing17 Apr 2026 - Key votes include director elections and redomestication to Texas for strategic and cost advantages.VOYG
Proxy filing17 Apr 2026 - Shareholders are asked to approve redomestication to Texas, director elections, and auditor ratification.VOYG
Proxy filing7 Apr 2026 - Record 2025 sales and backlog drive 2026 revenue guidance up 35–53% year-over-year.VOYG
Q4 202510 Mar 2026 - IPO seeks $274M for growth and Starlab; CEO retains control; high gov't revenue concentration.VOYG
Registration Filing29 Nov 2025 - IPO targets $274M+ for growth, R&D, and Starlab, but faces losses and funding risks.VOYG
Registration Filing29 Nov 2025 - IPO funds will drive growth and Starlab, but risks include losses and CEO control.VOYG
Registration Filing29 Nov 2025